In the present study, elevated levels of CD147 on iMonos and ncMonos was a general feature of all patients, while increased levels of CD147 on pDCs, pre-DCs, and pre-DC2s were specific to severe COVID-19. This evidence concerns the gene BSG and COVID-19.